Showing results (191-200 of 221) with videos related to
Sort By:
Pageof 23
The AAPS Journal|November 3, 2019
Phase-Appropriate Application of Analytical Methods to Monitor Subvisible Particles Across the Biotherapeutic Drug Product Life CycleRoman Mathaes, Linda Narhi, Andrea Hawe, et al.Thescientificworldjournal|December 3, 2013
Medium-chain acyl-CoA deficiency: outlines from newborn screening, in silico predictions, and molecular studiesSerena Catarzi, Anna Caciotti, Janita Thusberg, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 13, 2017
Lack of efficacy of Lactobacillus GG in reducing pulmonary exacerbations and hospital admissions in children with cystic fibrosis: A randomised placebo controlled trialEugenia Bruzzese, Valeria Raia, Eliana Ruberto, et al.Heliyon|March 7, 2024
Microbiology of cystic fibrosis persons not chronically infected with <i>P. aeruginosa</i>: A quasi-experimental study on two different upper airways' sampling methodsDaniela Dolce, Novella Ravenni, Cristina Fevola, et al.Children (Basel, Switzerland)|February 25, 2023
Nutritional Status and Circulating Levels of Fat-Soluble Vitamins in Cystic Fibrosis Patients: A Cohort Study and Evaluation of the Effect of CFTR ModulatorsMichela Francalanci, Vito Terlizzi, Cristina Fevola, et al.Gut|March 27, 2020
Adenoma detection by Endocuff-assisted versus standard colonoscopy in routine practice: a cluster-randomised crossover trialDavid Karsenti, Gaelle Tharsis, Bastien Perrot, et al.Clinical Kidney Journal|June 27, 2022
Erratum to: A roadmap to parathyroidectomy for kidney transplant candidatesGiuseppe Cianciolo, Francesco Tondolo, Simona Barbuto, et al.Clinical Kidney Journal|July 27, 2022
A roadmap to parathyroidectomy for kidney transplant candidatesGiuseppe Cianciolo, Francesco Tondolo, Simona Barbuto, et al.Leukemia|December 25, 2010
HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patientsP Storti, G Donofrio, S Colla, et al.Cancer Science|May 8, 2024
HER2 mutation as an emerging target in advanced breast cancerGiulia Bon, Francesca Sofia Di Lisa, Lorena Filomeno, et al.Pageof 23